Skip to main content
. Author manuscript; available in PMC: 2018 Jul 15.
Published in final edited form as: Clin Cancer Res. 2017 Feb 7;23(14):3592–3600. doi: 10.1158/1078-0432.CCR-16-2629

Table 1.

Final Flavopiridol Pharmacokinetic Model Parameter Estimates

Parameter Estimate %RSE Bootstrap (200 runs)
Estimate %RSE 2.5% CI 97.5% CI
tvFu (%) 10.9 2.00 10.9 2.03 10.5 11.4
tvV (L) 71.0 4.69 70.8 4.90 63.8 77.3
tvV2 (L) 88.8 8.34 91.4 13.6 67.4 118
tvCl (L/h) 33.4 3.87 33.7 4.54 30.9 36.6
tvCl2 (L/h) 8.95 12.3 9.28 16.2 6.40 12.5
Prop. RV (total) 34.9% 2.04 34.7% 6.26 30.5% 38.3%
Prop. RV (unbound) 34.1% 2.51 33.7% 5.05 30.4% 37.2%
Parameter Estimate %RSE Bootstrap (200 runs) η Shrinkage
Estimate %RSE
ηV (%) 41.0 44.3 42.7 66.2 9.79%
ηCl (%) 48.5 37.0 47.8 45.2 4.75%
ηCl2 (%) 199 9.33 161 26.4 5.63%
ηV2 (%) 98.3 22.3 100 26.5 11.2%

RSE= relative standard error; CI= confidence interval; Prop. RV = proportional residual variability